大行評級|大和:Milwaukee及Ryobi帶動創科實業穩健增長
大和發表研究報吿指,創科實業上半年收入按年增長6.3%,是受到Milwaukee及Ryobi分別達11.2%和中個位水平的穩健增長所帶動。創科的管理層指,公司全年整體收入指引為按年錄中個位數增長,又對今年下半年需求持續復甦充滿信心,並重申會致力於2026年前將營業利潤率提升至10%。報吿提到,創科的管理層認為Ryobi業務的復甦優於預期,是受惠於今年美國早春,户外設備需求強勁回升。至於Milwaukee業務的穩健增長,則受到電力公用設施及數據中心等行業所帶動。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.